Expert Recommendations for Use of Combined Oral Contraceptives in Preadolescent and Young Adolescent Patients With Acne Vulgaris
Pediatric Dermatology · 04.11.2026
DOI: 10.1111/pde.70325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 04.11.2026. Verfasst von Andrea L Zaenglein und 18 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology and Pediatrics, Penn State Hershey Medical Center, Penn State Children's Hospital, Hershey, Pennsylvania, USA. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acne vulgaris commonly presents in early adolescence with the onset of adrenarche. Treatments for acne in this age group typically mirror those in older adolescents. However, while combined oral contraceptives are an effective hormonal treatment for acne vulgaris in young women, the safety of using a systemic hormonal therapy in younger patients for the management of acne has not been established. Concerns include effects on pubertal development and weight, bone health, cancer risks, and psychiatric effects. This Pediatric Dermatology Research Alliance (PeDRA) consensus project convened a multidisciplinary work group to address these issues and, utilizing a modified Delphi process, to establish best practices regarding the use of combined oral contraceptives in patients under 16 years of age based on available evidence and expert opinion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Dermatology and Pediatrics, Penn State Hershey Medical Center, Penn State Children's Hospital, Hershey, Pennsylvania, USA.
- Department of Pediatrics, Division of Endocrinology and Diabetes, Penn State Children's Hospital, Hershey, Pennsylvania, USA.
- Department of Pediatrics, Division of Endocrinology, Nationwide Children's Hospital/the Ohio State University, Columbus, Ohio, USA.
- University of Texas Southwestern Medical School, Pediatric Dermatology Research Alliance, Oregon, Portland, USA.
- Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.
- Department of Obstetrics and Gynecology, Oregon Health & Science University School of Medicine, Oregon, Portland, USA.
ORCID-Profile: Andrea L Zaenglein, Natalie Allen, Sasigarn Bowden, Hannah R Chang, Kristina Derrick, Alison Edelman, Dawn Eichenfield, Lawrence Eichenfield, Sarah Gold, Sarah Horvath, Irene Lara-Corrales, Tierney E Wallace
Zitieren
APA
Zaenglein, A. L., Allen, N., Bowden, S., Chang, H. R., Derrick, K., Edelman, A., Eichenfield, D., Eichenfield, L., Gold, S., Graber, E., Harper, J., Horvath, S., Huguelet, P., Kartawira, K. J., Lalor, L., Lara-Corrales, I., Tollefson, M. M., Wallace, T. E., & Keri, J. (2026). Expert Recommendations for Use of Combined Oral Contraceptives in Preadolescent and Young Adolescent Patients With Acne Vulgaris. Pediatric Dermatology. https://doi.org/10.1111/pde.70325
Vancouver
Zaenglein AL, Allen N, Bowden S, Chang HR, Derrick K, Edelman A, et al. Expert Recommendations for Use of Combined Oral Contraceptives in Preadolescent and Young Adolescent Patients With Acne Vulgaris. Pediatric Dermatology. 2026. doi:10.1111/pde.70325
BibTeX
@article{Zaenglein2026,
author = {Zaenglein, Andrea L and Allen, Natalie and Bowden, Sasigarn and Chang, Hannah R and Derrick, Kristina and Edelman, Alison and Eichenfield, Dawn and Eichenfield, Lawrence and Gold, Sarah and Graber, Emmy and Harper, Julie and Horvath, Sarah and Huguelet, Patricia and Kartawira, Karin J and Lalor, Leah and Lara-Corrales, Irene and Tollefson, Megha M and Wallace, Tierney E and Keri, Jonette},
title = {Expert Recommendations for Use of Combined Oral Contraceptives in Preadolescent and Young Adolescent Patients With Acne Vulgaris},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70325}
}
EUVIMED